MGNX

Macrogenics Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↑ 7/10
  • Momentum↑ 5/10
Macrogenics sales and earnings growth
MGNX Growth
Good
  • Revenue Y/Y↓ -9.70%
  • EPS Y/Y↑ 24.05%
  • FCF Y/Y↓ -167.69%
Macrogenics gross and profit margin trends
MGNX Profitability
Low
  • Gross margin ↑ 75.40%
  • EPS margin↓ -59.50%
  • ROIC↓ -50.60%
Macrogenics net debt vs free cash flow
MGNX Risk
Good
  • Debt / Equity↓ 1.6
  • Debt / FCF↓ 0.2
  • Interest coverage↓ -16.8

Macrogenics stock volatility is higher than the overall market. We give it a Good risk rating.

More Biotechnology stocks ↗